N,N-dimethylcyclohexylamine: RN given refers to parent cpd
N,N-dimethylcyclohexylamine : A tertiary amine consisting of cyclohexane having a dimethylamino substituent.
ID Source | ID |
---|---|
PubMed CID | 7415 |
CHEMBL ID | 3186662 |
CHEBI ID | 59022 |
SCHEMBL ID | 15595 |
MeSH ID | M0115470 |
Synonym |
---|
CHEBI:59022 , |
dimethylcyclohexylamine |
cyclohexylamine, n,n-dimethyl- |
cyclohexanamine, n,n-dimethyl- |
brn 1919922 |
un2264 |
nsc 163904 |
einecs 202-715-5 |
hsdb 5323 |
n,n-dimethylaminocyclohexane |
dimethylcyclicsiloxane hydrolyzate |
n-cyclohexyldimethylamine |
wln: l6tj an1 & 1 |
98-94-2 |
n,n-dimethyl-n-cyclohexylamine |
nsc163904 |
(dimethylamino)cyclohexane |
n,n-dimethylcyclohexanamine |
cyclohexylamine,n-dimethyl- |
cyclohexanamine,n-dimethyl- |
n,n-dimethylcyclohexylamine |
cyclohexyldimethylamine |
nsc-163904 |
n,n-dimethylcyclohexylamine, 99% |
D0705 |
dimethylaminocyclohexane |
A845928 |
NCGC00249031-01 |
tox21_201360 |
NCGC00258912-01 |
dtxsid9026633 , |
cas-98-94-2 |
dtxcid906633 |
ec 202-715-5 |
unii-n1h19e7hta |
n1h19e7hta , |
dimethylcyclohexylamine [un2264] [corrosive] |
FT-0629528 |
AKOS015850797 |
cyclohexyl(dimethyl)ammonium |
SCHEMBL15595 |
n,n-dimethylcyclohexylamine [hsdb] |
n,n-dimethylcyclohexyl amine |
n, n-dimethylcyclohexylamine |
n-cyclohexyl-n,n-dimethylamine |
n,n-dimethyl-cyclohexylamine |
cyclohexyl-dimethylamine |
dimethyl cyclohexyl amin |
dimethyl cyclohexylamine |
W-100060 |
STR02891 |
un 2264 |
CHEMBL3186662 |
mfcd00003844 |
F0001-2323 |
Q25945666 |
8ia , |
Class | Description |
---|---|
tertiary amine | A compound formally derived from ammonia by replacing three hydrogen atoms by hydrocarbyl groups. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 74.1222 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159555 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 67.9623 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841; AID1224849 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 53.9844 | 0.0002 | 29.3054 | 16,493.5996 | AID743079 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 54.4372 | 0.0010 | 19.4141 | 70.9645 | AID743191 |
heat shock protein beta-1 | Homo sapiens (human) | Potency | 61.0796 | 0.0420 | 27.3789 | 61.6448 | AID743210 |
ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 76.2550 | 0.0119 | 17.9420 | 71.5630 | AID651632 |
Ataxin-2 | Homo sapiens (human) | Potency | 76.2550 | 0.0119 | 12.2221 | 68.7989 | AID651632 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
protein binding | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
ATP binding | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
ATP hydrolysis activity | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
DNA clamp unloader activity | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
DNA binding | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
RNA binding | Ataxin-2 | Homo sapiens (human) |
epidermal growth factor receptor binding | Ataxin-2 | Homo sapiens (human) |
protein binding | Ataxin-2 | Homo sapiens (human) |
mRNA binding | Ataxin-2 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
Elg1 RFC-like complex | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
nucleus | ATPase family AAA domain-containing protein 5 | Homo sapiens (human) |
cytoplasm | Ataxin-2 | Homo sapiens (human) |
Golgi apparatus | Ataxin-2 | Homo sapiens (human) |
trans-Golgi network | Ataxin-2 | Homo sapiens (human) |
cytosol | Ataxin-2 | Homo sapiens (human) |
cytoplasmic stress granule | Ataxin-2 | Homo sapiens (human) |
membrane | Ataxin-2 | Homo sapiens (human) |
perinuclear region of cytoplasm | Ataxin-2 | Homo sapiens (human) |
ribonucleoprotein complex | Ataxin-2 | Homo sapiens (human) |
cytoplasmic stress granule | Ataxin-2 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (35.14) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |